Cadila Pharma partners Wellesta in Singapore JV
Cadila Pharma partners Wellesta in Singapore JV. The Indian pharma company has formed a strategic joint venture with Wellesta Holdings Singapore to expand its global footprint. The move aims to strengthen presence in Southeast Asian markets. Financial details of the JV were not disclosed.
📊 STOCKS: CAPELLA | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #JointVenture
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.